Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats

Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats

Atypical antipsychotic drugs are commonly associated with undesirable side effects including body weight gain (BWG) and metabolic deficits. Many pharmacological interventions have been tested in an attempt to minimize or prevent these side effects. Preliminary evidence suggests that antidiabetic dru...

Full description

Bibliographic Details
Main Authors: Ghulam Md Ashraf, Badrah S. Alghamdi, Fahad S. Alshehri, Mohammad Zubair Alam, Haythum O. Tayeb, Frank I. Tarazi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
antidiabetics
antipsychotics
body weight gain
empagliflozin
olanzapine
wistar rats
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.578716/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.578716/full

Similar Items